Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Sorting of Drosophila small silencing RNAs partitions microRNA* strands into the RNA interference pathway.

Ghildiyal M, Xu J, Seitz H, Weng Z, Zamore PD.

RNA. 2010 Jan;16(1):43-56. doi: 10.1261/rna.1972910. Epub 2009 Nov 16.

2.

MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection.

Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE.

Clin Exp Metastasis. 2009;26(8):965-79. doi: 10.1007/s10585-009-9287-2. Epub 2009 Sep 22.

PMID:
19771525
3.

miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.

Epis MR, Giles KM, Barker A, Kendrick TS, Leedman PJ.

J Biol Chem. 2009 Sep 11;284(37):24696-704. doi: 10.1074/jbc.M109.030098. Epub 2009 Jul 7.

4.

MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.

Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E.

Int J Cancer. 2009 Sep 15;125(6):1407-13. doi: 10.1002/ijc.24522.

5.

Gene and microRNA expression in p53-deficient day 8.5 mouse embryos.

Hosako H, Martin GS, Barrier M, Chen YA, Ivanov IV, Mirkes PE.

Birth Defects Res A Clin Mol Teratol. 2009 Jun;85(6):546-55. doi: 10.1002/bdra.20565.

PMID:
19229884
6.

Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.

Schotte D, Chau JC, Sylvester G, Liu G, Chen C, van der Velden VH, Broekhuis MJ, Peters TC, Pieters R, den Boer ML.

Leukemia. 2009 Feb;23(2):313-22. doi: 10.1038/leu.2008.286. Epub 2008 Oct 16.

PMID:
18923441
7.

Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Cancer Genome Atlas Research Network.

Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4. Erratum in: Nature. 2013 Feb 28;494(7438):506.

8.

MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors.

Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick Yanai G, Elyakim E, Cholakh H, Gibori H, Spector Y, Bentwich Z, Barshack I, Rosenfeld N.

Brain Pathol. 2009 Jul;19(3):375-83. doi: 10.1111/j.1750-3639.2008.00184.x. Epub 2008 Jul 2.

9.

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.

Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM.

Mol Cell Biol. 2008 Sep;28(17):5369-80. doi: 10.1128/MCB.00479-08. Epub 2008 Jun 30.

10.

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.

Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, Li M.

Clin Cancer Res. 2008 Jun 1;14(11):3319-26. doi: 10.1158/1078-0432.CCR-07-4054.

11.

NF-kappaB and cancer-identifying targets and mechanisms.

Naugler WE, Karin M.

Curr Opin Genet Dev. 2008 Feb;18(1):19-26. doi: 10.1016/j.gde.2008.01.020. Epub 2008 Apr 24. Review.

12.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC.

JAMA. 2008 Jan 30;299(4):425-36. doi: 10.1001/jama.299.4.425.

13.

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD.

Clin Cancer Res. 2008 Jan 15;14(2):419-27. doi: 10.1158/1078-0432.CCR-07-0523.

14.

Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.

Hoelzinger DB, Demuth T, Berens ME.

J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93. Epub 2007 Oct 30. Review.

PMID:
17971532
15.

Making a tumour's bed: glioblastoma stem cells and the vascular niche.

Gilbertson RJ, Rich JN.

Nat Rev Cancer. 2007 Oct;7(10):733-6. doi: 10.1038/nrc2246. Review.

PMID:
17882276
16.

Tissue-dependent paired expression of miRNAs.

Ro S, Park C, Young D, Sanders KM, Yan W.

Nucleic Acids Res. 2007;35(17):5944-53. Epub 2007 Aug 28.

17.

Angiogenesis in brain tumours.

Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT.

Nat Rev Neurosci. 2007 Aug;8(8):610-22. Review.

PMID:
17643088
18.

Integrating cell-signalling pathways with NF-kappaB and IKK function.

Perkins ND.

Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62. Review.

PMID:
17183360
19.

MicroRNA signatures in human cancers.

Calin GA, Croce CM.

Nat Rev Cancer. 2006 Nov;6(11):857-66. Review.

PMID:
17060945
20.

Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas.

Birlik B, Canda S, Ozer E.

Neuropathol Appl Neurobiol. 2006 Oct;32(5):532-8.

PMID:
16972887

Supplemental Content

Support Center